4-Phenylmorpholine(CAS: 92-53-5)

4-Phenylmorpholine (CAS: 92-53-5) falls under several regulatory guidelines. It is classified under the Globally Harmonized System of Classification and Labeling of Chemicals (GHS) as a category 4 sensitiser. For European markets, it must comply with REACH regulations, which require registration, evaluation, and authorization for certain substances. In the US, FDA and EPA regulations apply, particularly for pharmaceutical and agricultural applications, requiring appropriate documentation and handling procedures.

There are several alternatives to 4-Phenylmorpholine (CAS: 92-53-5) in synthesis, including 3-Methylmorpholine, Pyrrolidine, and p-Toluidine. These alternatives offer similar functionalities but may differ in reactivity and toxicity, providing flexibility in chemical synthesis depending on the specific requirements of the reaction.

The market for 4-Phenylmorpholine (CAS: 92-53-5) is primarily driven by its use in pharmaceuticals, particularly in the development of antispasmodic and anti-inflammatory drugs. Research trends are shifting towards the development of more sustainable and less toxic alternatives. However, due to its unique properties, it remains a valuable compound in various chemical research areas, including drug discovery and functional material development.

Waste containing 4-Phenylmorpholine (CAS: 92-53-5) should be collected in sealed containers and stored in a secure, well-ventilated area. Disposal should be handled by a professional waste management company that specializes in hazardous waste. Proper protective equipment, such as gloves and goggles, should be worn during handling. Environmental protection measures include ensuring that no waste is released into water sources or the air. Compliance with local, national, and international regulations is crucial.